Organization Overview
Alternative names
allogeneic cord blood (1 trial)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (1 trial)
Bismuth Subcitrate Potassium (Pylera) (1 trial)
butorphanol (stadol) (1 trial)
cisplatin (platinol) (5 trials)
cyclosporine (sandimmune) (2 trials)
dexmedetomidine (precedex) (1 trial)
entecavir (baraclude) (1 trial)
esketamine (spravato) (1 trial)
esomeprazole (nexium) (2 trials)
allopurinol (zyloprim) (1 trial)
ambrisentan (letairis) (1 trial)
azacitidine (vidaza) (2 trials)
bortezomib (velcade) (1 trial)
capecitabine (xeloda) (3 trials)
decitabine (dacogen) (2 trials)
docetaxel (taxotere) (2 trials)
ferric citrate (AURYXIA) (1 trial)
alprostadil (prostin) (1 trial)
autologous cytokine induced killer cells (2 trials)
cytokine induced killer cells (2 trials)
diphenhydramine (benadryl) (1 trial)
abiraterone (zytiga) (1 trial)
amlodipine (norvasc) (1 trial)
anastrozole (arimidex) (2 trials)
amantadine (symmetrel) (1 trial)
autologous adipose-derived mesenchymal stem cells (1 trial)
autologous bone marrow derived mesenchymal cells (1 trial)
Anemia (Phase 4)
Anemia, Aplastic (Phase 4)
Arteriosclerosis (Phase 2)
Arteriosclerosis Obliterans (Phase 2)
Breast Neoplasms (Phase 3)
Carcinoma (Phase 2)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Renal Cell (Phase 2)
Cardiomyopathies (Phase 2)
Cardiomyopathy, Dilated (Phase 2)
Cardiovascular Diseases (Phase 3)
Cerebral Infarction (Phase 4)
Colitis (Phase 2)
Colitis, Ulcerative (Phase 2)
Diabetes Mellitus (Phase 2)
Diabetes Mellitus, Type 1 (Phase 2)
Diabetic Foot (Phase 2)
Digestive System Neoplasms (Phase 2)
Embolism (Phase 4)
Esophageal Neoplasms (Phase 3)
Fibrosis (Phase 4)
Gastrointestinal Neoplasms (Phase 2)
Gastroparesis (Phase 4)
Glioma (Phase 2)
Gout (Phase 3)
Hepatitis (Phase 4)
Hepatitis A (Phase 4)
Hepatitis B (Phase 4)
Hepatitis B, Chronic (Phase 4)
Hepatitis, Chronic (Phase 4)
Hepatoblastoma (Phase 4)
Hyperphosphatemia (Phase 3)
Hypertension (Phase 3)
Hypertension, Portal (Phase 4)
Hypertension, Pulmonary (Phase 3)
Immunoblastic Lymphadenopathy (Phase 2)
Ischemia (Phase 4)
Kidney Diseases (Phase 3)
Kidney Failure, Chronic (Phase 3)
Leukemia (Phase 4)
Leukemia, Lymphoid (Phase 4)
Leukemia, Myeloid (Phase 3)
Leukemia, Myeloid, Acute (Phase 3)
Liver Cirrhosis (Phase 4)
Lung Diseases (Phase 3)
Lung Diseases, Obstructive (Phase 4)
Lung Neoplasms (Phase 3)
Lymphoma (Phase 4)
Lymphoma, T-Cell (Phase 4)
Malnutrition (Phase 1)
May-Thurner Syndrome (Phase 3)
Neoplasms (Phase 2)
Neuroblastoma (Phase 4)
Neurotoxicity Syndromes (Phase 2)
Neutropenia (Phase 2)
Pulmonary Disease, Chronic Obstructive (Phase 4)
Pulmonary Embolism (Phase 4)
Purpura (Phase 3)
Purpura, Thrombocytopenic (Phase 3)
Purpura, Thrombocytopenic, Idiopathic (Phase 3)
Renal Insufficiency, Chronic (Phase 3)
Retinoblastoma (Phase 4)
Small Cell Lung Carcinoma (Phase 3)
Stroke (Phase 4)
Thrombocytopenia (Phase 3)
Thromboembolism (Phase 4)
Thrombosis (Phase 3)
Ulcer (Phase 2)
Venous Thromboembolism (Phase 3)
Venous Thrombosis (Phase 3)